FDA-cleared profile

HeartFocus (V.1.1.1)

Deski

Authorized purpose: HeartFocus v1.1.1 guides trained medical professionals in acquiring ten standard adult 2D transthoracic echocardiographic views using compatible ultrasound systems, with live probe guidance, image-quality feedback and recording assistance for subsequent clinical interpretation.

Evidence status: each field states its source quality, applicability, and review date. Research pending, information not established, and vendor documentation pending remain distinct outcomes.

Product overview

Start with the essentials

Authorized purpose: HeartFocus v1.1.1 guides trained medical professionals in acquiring ten standard adult 2D transthoracic echocardiographic views using compatible ultrasound systems, with live probe guidance, image-quality feedback and recording assistance for subsequent clinical interpretation.

Overview status: Source-reviewed overview

Clinical takeaway

Clinical role: HeartFocus v1.1.1 guides trained medical professionals in acquiring ten standard adult 2D transthoracic echocardiographic views using compatible ultrasound systems, with live probe guidance, image-quality feedback and recording assistance for subsequent clinical interpretation.

Evidence takeaway

Evidence from the reviewed source record: The initial Clarius/v1.1.1 evidence supports trained-user image acquisition with expert interpretation. Current Butterfly family features and commercial terms cannot be used as original-study results.

Clinical details

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
HeartFocus v1.1.1 guides trained medical professionals in acquiring ten standard adult 2D transthoracic echocardiographic views using compatible ultrasound systems, with live probe guidance, image-quality feedback and recording assistance for subsequent clinical interpretation.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Intended users
Medical professionals trained in ultrasound basics and HeartFocus use, including trained nurses, physicians and sonographers
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Care setting and population
Adult patients requiring cardiac ultrasound; prospective validation included clinically indicated exams at French and US centers
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Workflow role
Acquisition guidance and image-quality/recording assistance
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Required input
Live adult 2D-TTE ultrasound stream; initial compatibility lists Clarius PAHD3 wireless, PAHD, PAL and Clarius Ultrasound Scanner Software. Views: PLAX, PSAX-AV/MV/PM, A4C/A5C/A2C/A3C, SC-4C and SC-IVC.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Output and human action
Probe-position guidance cues, color-coded diagnostic-quality feedback, Auto Record, Best-Effort Record and recorded-clip quality information; acquired exams are available for clinician review and transfer.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Limitations
Adult acquisition aid requiring trained users and qualified interpretation. Clinical-study image quality varied by view, particularly subcostal IVC. PCCP allows specified compatibility changes after validation; it does not establish that every current probe/OS was tested in the initial v1.1.1 study.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K242807
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Anatomy
Heart/Cardiovascular
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-04-04
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
Connects to a compatible ultrasound system's image stream; collected exams can be transferred using DICOM protocols.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05

Specific PACS/RIS/EHR configuration and later ultrasound integrations need confirmation.

Deployment and data flow
The FDA summary describes an offline application with medical data stored locally on the tablet and no data transfer to a DESKi-controlled server for its functions.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05

Corrects the baseline's nonspecific Hybrid label using the exact summary; current device configuration remains separately scoped.

Security and privacy
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-05

FDA-local data flow is documented, but FAQ/pricing security language does not supply a dated scoped attestation or a complete installed security-control assessment.

Training and support
Users require ultrasound-basics and HeartFocus training provided by DESKi or a trained medical professional using approved training material.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05

Exact local competency sign-off, onboarding duration and contractual support remain site/vendor matters.

Monitoring and change control
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-05

Editorial acceptance questions concern installed probe/OS/model compatibility, per-view failures, rescue scanning, saved-clip review and DICOM transfer; no vendor monitoring service is verified.

Current family supported configuration

The current official FAQ describes Butterfly iQ+/iQ3 with supported iPad/iPhone devices, offline guidance, and DICOM PACS transfer.

product family · checked 2026-09-05

Current family documentation; the initial K242807 summary and clinical evidence describe Clarius. Verify installed release/probe linkage before use.

Clinician training

Ultrasound-basics and product training using approved materials are required.

exact submission · checked 2026-09-05

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The initial Clarius/v1.1.1 evidence supports trained-user image acquisition with expert interpretation. Current Butterfly family features and commercial terms cannot be used as original-study results.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Reported sensitivity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

A single disease-detection sensitivity is not established by the reviewed acquisition-quality studies.

Reported specificity
93.9%
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-13

Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.

Best-Effort Record diagnostic-quality clip yield

93.9 percent

  • EndpointProportion of clips saved with Best-Effort Record judged of diagnostic image quality in the prospective acquisition study
  • Population240 adults aged at least 22 at one French and one US center; eight nurse operators, five blinded cardiologist assessors; recorded clips graded using ACEP scale
  • Tested versionHeartFocus v1.1.1 with Clarius in K242807 clinical study

K242807 HeartFocus prospective acquisition study

  • DesignManufacturer prospective multicenter paired acquisition study; trained novice nurses compared with experts on the same ultrasound system, five blinded cardiologist reviewers
  • Population240 clinically indicated echocardiography patients aged at least 22; 120 France and 120 US
  • Scopeexact submission
  • Tested versionHeartFocus v1.1.1 with Clarius
  • Samplen=240
  • Sites2
  • IndependenceSponsor or vendor study

K242807

Eight nurses acquired ten views; four primary endpoints assessed examination suitability for visual LV size/function, RV size and nontrivial effusion evaluation. Secondary quality outcomes were descriptive and varied by view; not an autonomous diagnosis study.

K242807 HeartFocus algorithm performance testing

  • DesignManufacturer standalone evaluation of view classification, guidance cues and recording, with expert annotations
  • Population290 patients and 361,104 images in the test pool, with feature-specific subsets and additional retrospective evaluation of trial data
  • Scopeexact submission
  • Tested versionHeartFocus v1.1.1
  • Samplen=290
  • IndependenceSponsor or vendor study

K242807

The 290-patient algorithm pool and 240-patient clinical study are distinct denominators, not a single combined cohort.

Costs and setup

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
The current HeartFocus family pricing page displays $695 per license/year/probe or $1,800 per license/three years/probe for up to five licenses, with unlimited users; enterprise six-plus licenses require a quote.
  • Public source
  • Product family
  • Checked 2026-09-05

Current family offer, not an exact v1.1.1/Clarius quote. The page shows a dollar sign but no ISO currency; no normalized price observation is emitted. Hardware, tax and local contract inclusions require confirmation.

Reimbursement and coding
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-09-05

No applicable CMS policy content reviewed. Acquisition software pricing does not establish reimbursement for the software or the underlying echo service.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-05Last searched
21Fields reviewed
12Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads

Stored DESKi-sponsored PROSPECTIVE EVALUATION OF HEARTFOCUS metadata screened. Live registry page exposed only an application shell, so trial details and exact release linkage were not established; no registry result promoted. Clinical-study abstraction is sourced to the FDA summary only. Stored PubMed array empty. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, vendor pricing, literature index, trial registry, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall

Sources & history

How this profile was documented

Open the ledger for source dates, scope, and research-record updates.

View source ledger and history

Source ledger

  1. FDA 510(k) K242807: HeartFocus v1.1.1

    U.S. Food and Drug Administration - Accessed 2026-09-05

    Scope: identity, clinicalUse, modality, anatomy, implementationCapabilities, evidenceStudies, training

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. HeartFocus (V.1.1.1) model card (K242807)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, evidenceSummary, anatomy, evidenceStudies

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. HeartFocus official FAQ: current product family

    DESKi / HeartFocus - Accessed 2026-09-05

    Scope: productFamily, implementationCapabilities

  8. HeartFocus current family pricing

    DESKi / HeartFocus - Accessed 2026-09-05

    Scope: pricing, currentCommercialContext

Research history

  1. K242807 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K260780

HeartFocus

Deski

Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require...

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2026-06-03